all press releases

  • 05/29/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announced today it has received a Supplier Leadership Award from the Sustainable Purchasing Leadership Council (SPLC) for significant leadership in executing and supporting sustainable purchasing initiatives. The recognition was announced May 22. SPLC presented its 2018 Supplier Leadership Award to Vizient for helping standardize environmentally preferable purchasing across themore...
  • 05/16/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. will present at the Healthcare Transformation Summit being held May 16-17 in Austin, Texas. Byron Jobe, Vizient president and chief executive officer, will speak today on the panel “Disruption, Innovation, Transformation and New Avenues of Collaboration: The Supplier Perspective” at the Sheraton Austin Hotel. The event is produced by Modern Healthcare magazine. “Innovation occurs atmore...
  • 05/15/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. has again been selected by Modern Healthcare as one of the Best Places to Work in Healthcare. This is the third year in a row Vizient has been recognized. The complete alphabetical 2019 list of winners is available here. “This is further evidence that the culture we are nurturing at Vizient is one that fosters pride in the organization for our employees,” said Colleen Risk, chiefmore...
  • 05/14/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient offered its formal endorsement of the Affordable Prescriptions for Patients Act. This bipartisan Senate legislation targets “patent thickets” and other patent abuses that brand name pharmaceutical manufacturers utilize to delay market competition from generic and biosimilar drugs. The Affordable Prescriptions for Patients Act would enable the Federal Trade Commission (FTC) to take steps tomore...
  • 05/14/19
    WASHINGTON--(BUSINESS WIRE)--Vizient Inc.’s Senior Vice President for sourcing operations, David Gillan, today joins health care leaders from across the nation to discuss the needs and challenges caused by recent intravenous (IV) fluid shortages as well as finding sustainable solutions to alleviate future shortages. The panel, Be a Part of the Solution – Alleviating IV Fluid Shortages, is hosted by B. Braun Chairman and CEO Caroll H. Neubauermore...
  • 05/13/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. announced today the release of its 2018 Corporate Responsibility Report, prepared in accordance with the Global Report Initiative (GRI), the most widely adopted global standard for sustainability reporting. “Corporate responsibility is engrained in our values-based organization, and we voluntarily measure ourselves against GRI benchmarks to affirm our dedication to operating according tomore...
  • 05/13/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient Inc. announces that Steven Lucio, PharmD, BCPS, vice president, pharmacy solutions, will present on behalf of the company and its member hospitals at the Food and Drug Administration’s (FDA) public hearing “The Future of Insulin Biosimilars: Increasing Access and Facilitating the Efficient Development of Biosimilar and Interchangeable Insulin Products,” being held from 9 a.m. to 2:45 p.m. today at the FDA Whitemore...
  • 05/07/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today submitted comments to the Food and Drug Administration (FDA) in response to its published draft guidance on the nonproprietary naming of biological products. We applaud the FDA’s decision not to require the addition of suffixes to the nonproprietary names of previously approved originator biologics as well as transitional biological products. However, Vizient continues to bemore...
  • 05/06/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced the product categories and supplier savings opportunities available as part of its Quarter 2 National Group Buys Program available now through June 30. The National Group Buys program is one of several strategic programs from Vizient designed to deliver additional cost savings to its member hospitals. Philips Healthcare, the featured supplier for Quarter 2, is offeringmore...
  • 05/02/19
    IRVING, Texas--(BUSINESS WIRE)--Vizient commends the House Judiciary Committee for advancing the CREATES Act, and three other pieces of bipartisan legislation designed to promote competition and lower drug prices. Vizient has strongly supported the CREATES Act, which will take needed steps to support generic manufacturers market access to needed samples that will help to bolster generic competition. “We are pleased tomore...